You are here
Cabaletta Bio Appoints Experienced Financial Executive, Richard Henriques, to its Board of Directors
RADNOR, Pa., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc., a biotechnology company focused on the discovery and development of cellular therapies for B cell-mediated autoimmune diseases, announced today the appointment of Mr. Richard C. Henriques, Jr., MBA, to its Board of Directors. He will also be a Chair of the Audit Committee. Mr. Henriques joins Cabaletta with more than 25 years of financial executive experience.
Tuesday, February 19, 2019 - 08:00